Back to Search
Start Over
Efficacy and safety of a new heterologous fibrin biopolymer on socket bone healing after tooth extraction: An experimental pre‐clinical study.
- Source :
-
Journal of Clinical Periodontology . Aug2024, Vol. 51 Issue 8, p1017-1033. 17p. - Publication Year :
- 2024
-
Abstract
- Aim: To assess the efficacy of heterologous fibrin biopolymer (HFB) in promoting alveolar bone healing after tooth extraction in rats. Materials and Methods: The upper right incisors of 48 Wistar rats were extracted. Toothless sockets were filled with HFB (HFBG, n = 24) or blood clot (BCG, n = 24). The tooth extraction sites were subjected to micro‐computed tomography (micro‐CT), histological, histomorphometric and immunohistochemical (for Runt‐related transcription factor 2/Runx2 and tartrate‐resistant acid phosphatase/TRAP) analyses on days 0, 7, 14 and 42 after extraction. Results: Socket volume remained similar between days 0 and 14 (69 ± 5.4 mm3), except in the BCG on day 14, when it was 10% lower (p =.043). Although the number of Runx2+ osteoblasts was high and similar in both groups (34 × 102 cells/mm2), the HFBG showed lower inflammatory process and osteoclast activity than BCG at 7 days. On day 14, the number of Runx2+ osteoblasts remained high and similar to the previous period in both groups. However, osteoclast activity increased. This increase was 55% lower in the HFBG than BCG. In the BCG, the presence of an inflammatory process and larger and numerous osteoclasts on day 14 led to resorption of the alveolar bone ridge and newly formed bone. On day 42, numbers of Runx2+ osteoblast and TRAP+ osteoclasts decreased dramatically in both groups. Although the BCG exhibited a more mature cortical bone formation, it exhibited a higher socket reduction (28.3 ± 6.67%) and smaller bone volume (37 ± 5.8 mm3) compared with HFBG (socket reduction of 14.8 ± 7.14% and total bone volume of 46 ± 5.4 mm3). Conclusions: HFB effectively suppresses osteoclast activity and reduces alveolar bone resorption compared with blood clot, thus preventing three‐dimensional bone loss, particularly during the early healing period. HFB emerges as a promising biopharmaceutical material for enhancing healing processes after tooth extraction. [ABSTRACT FROM AUTHOR]
- Subjects :
- *WOUND healing
*BIOLOGICAL models
*BONE resorption
*PROTEINS
*ACID phosphatase
*RESEARCH funding
*FIBRIN
*COMPUTED tomography
*BONE growth
*BIOPOLYMERS
*BIOLOGICAL products
*DESCRIPTIVE statistics
*RATS
*EXPERIMENTAL design
*INCISORS
*DRUG efficacy
*ANIMAL experimentation
*OSTEOCLASTS
*DENTAL extraction
*COMPARATIVE studies
*ALVEOLAR process
*THROMBOSIS
*PERIODONTITIS
*EVALUATION
Subjects
Details
- Language :
- English
- ISSN :
- 03036979
- Volume :
- 51
- Issue :
- 8
- Database :
- Academic Search Index
- Journal :
- Journal of Clinical Periodontology
- Publication Type :
- Academic Journal
- Accession number :
- 178558658
- Full Text :
- https://doi.org/10.1111/jcpe.13992